PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

BMS Opdivo-Yervoy combo fails in kidney cancer trial

Bristol Myers Squibb’s kidney cancer drug yielded disappointing trial results when used as a post-surgery combination treatment for patients with localized renal cell carcinoma.

A data review panel found that the combination of Opdivo (nivolumab) plus Yervoy (ipilimumab) wasn’t much better than the placebo at preventing relapse or death in patients.

While the phase 3 CheckMate -914 trial did not meet its primary endpoints, the combo did have a safety profile that was consistent with previous studies of the drugs used on solid tumours.

Despite the recent flop, Opdivo was the first PD-1 immune checkpoint inhibitor to receive regulatory approval and has many indications approved for other cancers by itself, and in combination with Yervoy.

Part B of the CheckMate -91 trial tests Opdivo alone compared to placebo and is still ongoing.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026